US Tests Combo Pill Likely To Prevent Heart Attack And Strokes

A drug that is a combination of four medicines which are given for heart ailments and strokes has been developed for the first time in the United States and completed initial tests. The drug aimed towards low income group has already worked well in countries that have limited access to healthcare. The pill made up of low doses of 3 BP drugs and 1 cholesterol drug has already been tested on a small group of 300 people within age group of 45–75 that were part of a community healthcare center located at Alabama. These were split into two equal group of which half were given the combo pill while half were asked to continue usual medication.

After a year when both groups were tested it was discovered that blood pressure of people in poly-pill group and also their bad cholesterol had reduced by meaningful level to more than the level of other group. Though the study was not long enough to gauge effect on heart attacks strokes, a similar test in Iran found that it reduced likelihood of stroke, heart attack and heart failure by one third. The Iran study was carried out on a large group of 6800 people over a period of 5 years.

But till data the concept of polypill was alien to United States and doctors here see little need of such combinations as they prefer to have tailor-made medication for patients. But they cannot customize medications by pharma companies due to lack of time and patients’ dislike of returning back. The details of this research study have been published this Wednesday in New England Journal of Medicine and it was funded by NIH and American Heart association. The people in this research group were earning less than $15,000 and were mostly black. After excluding people that were borderline blood pressure patients the researchers also excluded people with high cholesterol.

David Sandefur

David Sandefur has gained a lot of experience in business and market analysis. He is one of the top assets for Chemical Industry Reports news portal. He is assigned with the title of “Gem” owing to his efficient way of managing the allotted responsibilities. He is competent in expressing terminologies and concepts related to business, finance, market, and industries. He had worked as a business analyst in the production industry for almost 4 Years with a total experience of 7 Years. These qualities and experience have served him the role of leading the columnists’ team at Chemical Industry Reports news portal. He has accomplished his Master’s degree in Accounts.

Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

Trump Says Not Looking For A Partial Deal With China

Tue Sep 24 , 2019
On Friday, the American President stated that he doesn’t have to make any trade deals with the Chinese government before the presidential elections which are due for the next year. While giving a press interview from White House, Donald Trump stated that he doesn’t think that there is any need […]
Trump Says Not Looking For A Partial Deal With China